Leaflet NOLPAZA 40mg powder for solution for injection

Product code:
W55858001
Quantity:
1
Indicated for:
peptic ulcer; gastroesophageal reflux
Route of administration:
injectable
Substance:
pantoprazole (proton pump inhibitor)
ATC
A02BC02 — Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Proton pump inhibitors
Pantoprazole is a proton pump inhibitor used to reduce stomach acid production. It is prescribed for conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and gastric or duodenal ulcers.

Pantoprazole effectively relieves symptoms like heartburn, acid regurgitation, and epigastric pain. It is also used to prevent gastric ulcers caused by long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs).

Pantoprazole is generally well-tolerated but may cause side effects such as headaches, nausea, diarrhea, or constipation. Long-term use may increase the risk of bone fractures, vitamin B12 deficiency, and gastrointestinal infections.

Pantoprazole is available as tablets or injectable solutions and should be taken as directed by a doctor. It is important not to stop treatment without medical advice, as symptoms may return.
NOLPAZA 40mg powder for solution for injection KRKA, pantoprazole

General data about NOLPAZA 40mg

Substance:
pantoprazole
Date of latest medicines list:
01-06-2016
Product code:
W55858001
Concentration:
40mg
Pharmaceutical form:
powder for solution for injection
Quantity:
1
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
KRKA D.D., NOVO MESTO - SLOVENIA
Holder:
KRKA, D.D., NOVO MESTO - SLOVENIA
Number:
9011/2016/01
Shelf life:
3 years-after packing for marketing;after reconstitution-it is used immediately

Concentrations available for pantoprazole

  • 20mg
  • 40mg